When CHD is taken into account, obesity is independently associated to the elevation of circulating hs-cTnT, a biomarker of myocardial injury, potentially indicating the impact of obesity on non-ischemic subclinical myocardial injury. This evidence concerns the gene TNNT2 and obesity due to melanocortin 4 receptor deficiency.